The Denmark-based pharmaceutical giant has lost ground in the weight-loss market to its biggest competitor, Eli Lilly, over the past couple of years. It has had to reduce its guidance several times ...

Retatrutide helped trial participants lose up to 28.7% of their body weight, but experts warn about excessive weight loss.

The Allurion gastric balloon can be swallowed in a 15-minute office visit and lead to a weight loss of up to 14 percent in 4 ...

Relations among brand-name GLP-1 manufacturers and compounding pharmacies are deteriorating as weight loss pills enter the U.S. market and competition intensifies. Hims & Hers is selling the ...

A deep-dive analysis of the Metabo Drops supplement, including ingredient science, absorption mechanics, consumer behavior patterns, safety signals, pricing logic, and why liquid metabolism drops are ...

Weight-loss pills now coming to market could be a boon to airlines' bottom line, according to an analysis by equity researchers at Jefferies. The first oral prescription GLP-1 weight loss medication, ...

Airlines could have weight loss drug manufacturers to thank for savings if passengers become lighter, allowing carriers to spend less money on fuel. As GLP-1 medications for weight loss become ...

Though recent data shows a meaningful decrease in the U.S. adult obesity rate (37 percent in 2025 compared with a record high of 39.9 percent in 2022), the need for obesity treatments is still ...

Structure Therapeutics Inc.’s experimental weight-loss pill hasn’t been approved yet, but the company is already worried about copycat versions flooding the market. “It’s the thing I fear the most,” ...

LUBBOCK, Texas (KCBD) - Weight loss medication Wegovy is now available in pill form, offering the same active ingredient as weekly injections but in a daily oral dose that could make the treatment ...

Wall Street is finding an unexpected beneficiary of America's weight loss boom: airlines. With the first GLP-1 weight loss drug now available in pill form, analysts at Jefferies say broad adoption ...

Both companies now aim to win in the oral weight loss drug market. The companies make GLP-1 drugs, products that interact with hormonal pathways involved in the digestion process -- and these types of ...